Ranibizumab 0.5 mg for Diabetic Macular Edema with Bimonthly Monitoring after...

lzliuzhuo_ylyy

题名	Ranibizumab 0.5 mg for Diabetic Macular Edema with Bimonthly Monitoring after a Phase of Initial Treatment: 18-Month, Multicenter, Phase IIIB RELIGHT Study.
链接	https://www.ncbi.nlm.nih.gov/pubmed/?term=26150052

https://www.ncbi.nlm.nih.gov/pubmed/?term=26150052

pnas2009

链接: https://pan.baidu.com/s/1dKPcg2IPu7cmZr02Nh9JRQ 提取码: 3ytm 复制这段内容后打开百度网盘手机App，操作更方便哦